Bruce Larry Wilkoff

Learn More
Clyde W. Yancy, MD, MSc, FACC, FAHA Mariell Jessup, MD, FACC, FAHA Biykem Bozkurt, MD, PhD, FACC, FAHA Frederick A. Masoudi, MD, MSPH, FACC, FAHA Javed Butler, MBBS, FACC, FAHA Patrick E. McBride, MD, MPH, FACC Donald E. Casey, John J.V. McMurray, MD, FACC Mark H. Drazner, MD, MSc, FACC, FAHA Judith E. Mitchell, MD, FACC, FAHA Gregg C. Fonarow, MD, FACC,(More)
CONTEXT Cardiac resynchronization therapy (CRT) through biventricular pacing is an effective treatment for heart failure (HF) with a wide QRS; however, the outcomes of patients requiring CRT and implantable cardioverter defibrillator (ICD) therapy are unknown. OBJECTIVE To examine the efficacy and safety of combined CRT and ICD therapy in patients with(More)
Cleveland Clinic, Department of Cardiovascular Medicine, Cleveland, OH, Ohio State University, Division of ardiovascular Medicine, Columbus, OH, Broward General Medical Center, Fort Lauderdale, FL, University Hospital, ivision of Cardiovascular Medicine, Pisa, Italy, University of Miami, Cardiothoracic Surgery, Miami, FL, St. Thomas esearch Institute,(More)
CONTEXT Implantable cardioverter defibrillator (ICD) therapy with backup ventricular pacing increases survival in patients with life-threatening ventricular arrhythmias. Most currently implanted ICD devices provide dual-chamber pacing therapy. The most common comorbid cause for mortality in this population is congestive heart failure. OBJECTIVE To(More)
BACKGROUND Delayed lead perforation (occurring more than 1 month after implantation) is a rare complication. Its pathophysiology and optimal management are currently unclear. METHODS Three cases of delayed lead perforation (6-10 month) were identified in patients with low-profile active fixation leads. RESULTS All cases presented in a subacute fashion(More)
OBJECTIVES Our purpose was to demonstrate that strategically chosen implantable cardioverter-defibrillator (ICD) ventricular tachycardia (VT) or ventricular fibrillation (VF) detection and therapy parameters can reduce the combined incidence of device-delivered shocks, arrhythmic syncope, and untreated sustained symptomatic VT/VF (morbidity index). (More)
The procedure of lead removal has recently matured into a definable, teachable art with its own specific tools and techniques. It is now time to recognize and formalize the practice of lead removal according to the current methods of medicine and the health care industry. In addition, since at this time the only prospective scientific study of lead(More)
BACKGROUND Optimal treatment of infections related to implantable electrophysiologic cardiac devices is poorly defined. OBJECTIVE To describe the clinical presentation, treatment, and outcome of patients with such infections. DESIGN Retrospective case series. SETTING The Cleveland Clinic Foundation, Cleveland, Ohio. PATIENTS 123 patients with(More)
BACKGROUND Delivery of inappropriate shocks caused by misdetection of supraventricular tachycardia (SVT) remains a substantial complication of implanted cardioverter/defibrillator (ICD) therapy. Whether use of optimally programmed dual-chamber ICDs lowers this risk compared with that in single-chamber ICDs is not clear. METHODS AND RESULTS Subjects with a(More)
Implantable Electronic Devices (CIEDs): Description of Techniques, Indications, Personnel, Frequency and Ethical Considerations Developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European(More)